Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Sarah Elizabeth Turbett, M.D.

Concepts (227)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Sarah Turbett's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Sarah Turbett has written about over time.
Exanthema, 5 publications between 2014 and 2024, average publication date April 2018. Enterobacteriaceae Infections, 3 publications between 2016 and 2023, average publication date April 2020. Feces, 5 publications between 2016 and 2024, average publication date May 2020. Syphilis, 2 publications between 2016 and 2024, average publication date June 2020. Anaplasma phagocytophilum, 3 publications between 2020 and 2022, average publication date November 2020. Enterobacteriaceae, 5 publications between 2016 and 2023, average publication date November 2020. Arthritis, 2 publications between 2017 and 2024, average publication date February 2021. Anaplasmosis, 2 publications between 2020 and 2022, average publication date March 2021. Hafnia, 1 publications between 2023 and 2023, average publication date April 2023. Anti-Infective Agents, 2 publications between 2023 and 2023, average publication date June 2023. Borrelia, 2 publications between 2023 and 2023, average publication date September 2023. Lyme Disease, 3 publications between 2023 and 2024, average publication date January 2024. Borrelia burgdorferi, 2 publications between 2023 and 2024, average publication date January 2024.

To see the data from this visualization as text, click here.
Turbett's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (227)
Explore
_
Co-Authors (136)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.